OGI
Organigram HoldingsOGI
OGI
About: Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Employees: 1,150
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
8% more call options, than puts
Call options by funds: $67K | Put options by funds: $62K
0.72% less ownership
Funds ownership: 5.6% [Q4 2024] → 4.88% (-0.72%) [Q1 2025]
20% less funds holding
Funds holding: 80 [Q4 2024] → 64 (-16) [Q1 2025]
45% less capital invested
Capital invested by funds: $11.4M [Q4 2024] → $6.25M (-$5.11M) [Q1 2025]
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
Research analyst outlook
We haven’t received any recent analyst ratings for OGI.
Financial journalist opinion
Based on 3 articles about OGI published over the past 30 days
Positive
MarijuanaStocks
2 weeks ago
June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth
As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasing consumer demand, introducing innovative products, and technological advancements in cultivation and production. Despite federal prohibition, 24 states have legalized adult-use cannabis, and 39 states have legalized medical cannabis. However, federal legalization efforts face challenges. In May 2025, the 1st U.S. Circuit Court of Appeals upheld the federal ban on marijuana, rejecting a legal challenge by several Massachusetts cannabis businesses. This decision underscores the ongoing tension between federal law and evolving state cannabis regulations. Additionally, while the Biden administration has proposed reclassifying marijuana to a less restricted category, the outcome remains uncertain, especially under a new administration.
Neutral
Business Wire
2 weeks ago
Organigram Global Announces CEO Succession Plan
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including.
Positive
Seeking Alpha
4 weeks ago
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands
Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.
Neutral
Zacks Investment Research
1 month ago
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Positive
Benzinga
1 month ago
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn
Cannabis grower Organigram Holdings Inc OGI reported second-quarter 2025 net sales of $45.7 million (approximately CA$65.6 million). That's up 74% year-over-year, beating the consensus of $42.28 million.
Neutral
Seeking Alpha
1 month ago
Organigram Global Inc. (OGI) Q2 2025 Earnings Call Transcript
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
Negative
Zacks Investment Research
1 month ago
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Neutral
Business Wire
1 month ago
Organigram Reports Record Second Quarter Fiscal 2025 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (“Q2 Fiscal 2025”). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in.
Neutral
Business Wire
1 month ago
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC b.
Neutral
Business Wire
1 month ago
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick (“ONB”) as part of the 2025 New Brunswick Export Awards, ONB's flagship annual event recognizing the successes and innovative approaches of New Brunswick's many exporting companies. This honour recognizes Organigram's significant growth in internationa.
Charts implemented using Lightweight Charts™